Showing 841 - 860 results of 108,878 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( e ((mean decrease) OR (point decrease)) ))', query time: 1.45s Refine Results
  1. 841

    Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

    Published 2019
    “…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”
  2. 842
  3. 843
  4. 844
  5. 845

    The number of behavioral arrests in DKO mice decreased following systemic atropine. by Mike Kalogiannis (224818)

    Published 2011
    “…<p>(A) Mean (± SEM) time per mouse spent in full behavioral arrests are plotted in 30 min bins across the entire recording period following IP injections of saline (open symbols) and atropine (0.5 mg/kg; filled symbols). …”
  6. 846

    GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

    Published 2021
    “…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10<sup>4</sup>) were plated in Transwell<sup>®</sup> inserts and allowed to invade for 1 week through a Matrigel<sup>™</sup> layer. …”
  7. 847
  8. 848
  9. 849
  10. 850
  11. 851
  12. 852

    Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux. by Parameswaran G. Sreekumar (176748)

    Published 2012
    “…GSH release from MRP1-silenced ARPE-19 cells incubated with 150 µM H<sub>2</sub>O<sub>2</sub> for 5 h in serum free medium. A significant decrease (P<0.001 vs scrambled control) in GSH release was observed in 5 h. …”
  13. 853
  14. 854
  15. 855
  16. 856
  17. 857
  18. 858
  19. 859
  20. 860

    The wound healing microenvironment decreased lung CSCs and induced cell apoptosis. by Linxin Liu (829738)

    Published 2015
    “…The results are presented as mean±SE (n = 5/group) **<i>p</i> < 0.01 <i>vs</i> control group. …”